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Abstract
Background Idiopathic acute pancreatitis is diagnosed in approximately 10–30 % of cases of acute pancreatitis. While there is
evidence to suggest that the cause in many of these patients is microlithiasis, this fact has not been translated into a resource
efficient treatment strategy that is proven to reduce recurrence rates. The aim of this study was to examine the value of
prophylactic cholecystectomy following an episode of acute pancreatitis in patients with no history of alcohol abuse and no
stones found on ultrasound.
Methods This was a retrospective study of 2236 patients who presented to a regional Australian hospital. Patients were included
when diagnosed with acute pancreatitis with no confirmed cause. Recurrence of acute pancreatitis was compared between those
that did and did not undergo cholecystectomy.
Results One hundred ninety-five consecutive patients met the study definition of Bidiopathic^ acute pancreatitis. 33.8% (66/195)
underwent cholecystectomy. The patients who had cholecystectomy had a recurrence rate of 19.7 % (13/66) whereas, of those
managed expectantly, 42.8 % (68/159) had at least one recurrence of acute pancreatitis (P = 0.001).
Conclusions Following an episode of acute pancreatitis with no identifiable cause, in patients fit for surgery, cholecystectomy
should be considered to reduce the risk of recurrent episodes of pancreatitis.
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Introduction
Gallstones and alcohol are by far the most common causes of
cases of acute pancreatitis. However, a definite cause is unable
to be determined in 10–30 % of patients so that a diagnosis of
idiopathic acute pancreatitis is assumed.1 The 2013 guidelines
published by the American College of Gastroenterology and the
IAP/APAWorkingGroup 2
, 3 suggest that patients with idiopath-
ic acute pancreatitis warrant further assessment by endoscopic
ultrasound or magnetic resonance cholangiopancreatography to
identify microlithiasis, neoplasms or chronic pancreatitis.
However, these recommendations are weak, based on low qual-
ity evidence, and access to such investigations is often limited
within the public health system.
Microlithiasis is frequently implicated as a cause of
Bidiopathic^ acute pancreatitis (IAP). There is some uncer-
tainty about the possible role of biliary microlithiasis as a
causative factor for pancreatitis as it is possible that pancrea-
titis itself modifies the contents of the gallbladder.1
, 4
However, treatment of presumed microlithiasis and biliary
sludge with cholecystectomy has been shown to prevent sub-
sequent attacks.4
, 5 While both terms are often used inter-
changeably, microlithiasis is the presence of stones less than
3 mm in diameter, and biliary sludge is a suspension of cho-
lesterol monohydrate crystals or calcium bilirubinate granules.
Previous studies have shown that microlithiasis is present in
70–75 % of IAP patients, and subsequent cholecystectomy or
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treatment with a cholelitholytic bile acid prevents relapse
when microlithiasis is confirmed.4
–6 However, more recent
long-term follow-up study suggested that microlithiasis is
not a significant cause of IAP in a predominantly male
population.7
The optimal method for detection of microlithiasis or bili-
ary sludge is yet to be determined, and trans-abdominal ultra-
sound has a significant false negative rate.1 When examining
liver function tests in inpatients with pancreatitis, an alanine
transaminase (ALT) level of greater than 150 IU/L is regarded
as the best serum indicator of gallstones as the aetiology.8
The definition of idiopathic acute pancreatitis varies be-
tween published articles.1 The most stringent requires an ex-
tensive evaluation that is beyond the scope of most public
hospital systems. For the purposes of this study, IAP is acute
pancreatitis where a causative factor cannot be determined
through history, physical examination, laboratory studies and
non-invasive imaging such as trans-abdominal ultrasound or
computerised tomography. Where no other cause has been
identified and occult cholelithiasis or microlithiasis is
suspected and not seen on ultrasound, common practice in
some acute surgical units is to perform cholecystectomy at
the primary, or more commonly, the second episode of acute
pancreatitis. The aim of this study was to examine the value of
prophylactic cholecystectomy following recovery from an ep-
isode of acute pancreatitis with no stones on ultrasound and no
history of alcohol abuse.
Materials and Methods
This was a retrospective study of 2236 patients that presented
to the University Hospital Geelong, Australia with acute pan-
creatitis from January 2005 through to January 2015.
Idiopathic acute pancreatitis was diagnosed where a causative
factor could not be determined through history, physical ex-
amination, laboratory studies and non-invasive imaging such
as trans-abdominal ultrasound or computerised tomography.
Patients who had been investigated with trans-abdominal ul-
trasound, not had prior cholecystectomy, had no identifiable
non-biliary cause and had no cholelithiasis seen on ultrasound
were included in the study. Non-biliary causes were excluded
by close review of clinical notes from hospital admissions,
emergency department presentations and outpatient reviews.
Radiological investigations were also closely examined.
Access to endoscopic ultrasound over the study period was
limited, and only four patients underwent this investigation.
All four were excluded from the study. To prevent the acci-
dental inclusion of patients affected by alcohol, patients were
only included where the clinician had specifically remarked in
the notes that alcohol was not thought to be a causative factor.
Recurrent episodes of acute pancreatitis were compared
between the patients that had been conservatively managed
and those that had undergone cholecystectomy.
Data collected included demographics, dates of recurrent
episodes or cholecystectomy, serum liver enzyme values,
trans-abdominal ultrasound and magnetic resonance
cholangiopancreatography (MRCP) results. Where cholecys-
tectomy had been performed, the pathologist’s report findings
were recorded.
Recurrent episodes were determined through review of
hospital admission records, community, private hospital and
public hospital pathology results and radiological studies from
three providers within the region at the time of the study.
Statistical analyses were performed using MedCalc for
Windows, version 16.1 (MedCalc Software, Ostend,
Belgium). Statistical analysis was performed using Fisher’s
exact test. P values less than 0.050 were considered to be
statistically significant. This study was given ethics approval
by the Research, Ethics, Governance and Integrity Unit of
University Hospital Geelong (Project Number 15/153).
Results
One hundred ninety-five consecutive patients met the study
definition of the study population and were followed for a
minimum of 6 and an average of 50 months. One hundred
of the patients were male. The median age was 54 years
(15–93 years). Of the complete cohort of patients, 73
(37.4 %) had at least one recurrent episode. For all 195 pa-
tients, there was another documented medical encounter with-
in the region that confirmed they had not left the region.
Cholecystectomy Versus Expectant Management
Of the complete cohort of patients, 33.8 % (66/195)
underwent cholecystectomy by the end of the follow-up peri-
od. The patients who had cholecystectomy had a recurrence
rate of 19.7% (13/66) whereas, of those managed expectantly,
42.8 % (68/159) had at least one recurrence of acute pancre-
atitis (Table 1). Thirty of the patients that recurred after initial
expectant management then went on to have a cholecystecto-
my after one or multiple subsequent episodes; that decision
was made at the discretion of the treating surgeon. Of the 66
patients that underwent cholecystectomy, there was no mor-
tality and one bile duct injury.
After a primary episode of acute pancreatitis, 159 patients
were managed expectantly and 36 had cholecystectomy
(Table 2). 42.8 % (68/159) had at least one recurrent episode
with expectant management only. A total of 66/195 patients
included in the study underwent cholecystectomy, 36 after the
primary episode, 23 after a second episode and seven after
three or more episodes. Of those that underwent cholecystec-
tomy after their primary episode, 13.9 % had another episode
1998 J Gastrointest Surg (2016) 20:1997–2001
of acute pancreatitis. Of the 68/159 that had a second episode
after expectant management (Table 3), 23 underwent chole-
cystectomy and six of these had a recurrent episode. A similar
recurrence rate was seen in the 45 that continued with expec-
tant management after a second episode. Thirteen of these
patients had a least one further episode. To enable analysis
of the most appropriate time to perform cholecystectomy,
the data were analysed separately for a primary episode and
second episode (Tables 2 and 3).
Radiological Investigations
Trans-abdominal ultrasound showed a normal gallbladder in
175 patients. The number of patients with no ultrasound evi-
dence of stones but either sludge or polyps was 14 and 6,
respectively (patients with cholelithiasis or anatomical causes
for pancreatitis were excluded from the study). Of those with
sludge, 12 eventually underwent cholecystectomy. Expectant
management was initially trialled in four of the patients with
sludge, but recurrent episodes in two led to cholecystectomy
and no subsequent episodes. Ultrasound discovered one or
more polyps in six patients, five of which underwent chole-
cystectomy, with four of those having at least one recurrence
prior. No polyposis patients had recurrent pancreatitis after
cholecystectomy. One patient of the six had conservativeman-
agement throughout the follow-up period without recurrence
of pancreatitis.
Fifty-one (26.2 %) patients were investigated with
MRCP at some time during the follow-up period. In total,
41 patients had a normal result (no cholelithiasis). Twenty-
seven patients with a normal MRCP went on with conser-
vative treatment, and 14 underwent cholecystectomy.
These patients had five and two recurrent episodes, respec-
tively. A total of 23 patients had an MRCP prior to cho-
lecystectomy. Five of these had sludge, three had tiny
stones and one confirmed a gallbladder polyp seen on
ultrasound (but was not present on histopathology). None
of the patients with cholelithiasis, sludge or microlithiasis
seen on MRCP had a recurrent episode of pancreatitis
after cholecystectomy. Three patients with small stones
on MRCP were excluded from the final analysis.
Liver Enzymes
In the first 48 h of the primary episode of IAP, the maximum
serum value of the liver enzyme ALT was elevated at greater
than 150 IU/L in a total of 23 patients. Seventeen went on to
have cholecystectomy, and six were managed expectantly with
one recurrence in each treatment cohort. Histopathological re-
cords of the cholecystectomy specimen reported cholelithiasis
in only 13 (19.7 %) of the total 66 cholecystectomy specimens.
Ultrasound was normal in eight of these patients, had suggested
sludge in three and a polyp in two of the gall bladders. ALT did
not predict real cholelithiasis in the patients of this study.
Discussion
This study represents the first investigation of the value of
cholecystectomy for preventing recurrent episodes of acute
Table 2 Patient characteristics
for patients managed expectantly
versus with cholecystectomy after
primary episode of idiopathic
acute pancreatitis
Characteristic Total Expectant management
(n = 159)
Cholecystectomy
(n = 36)
P value
Age, years, median, range 54 (15–93) 54 (15–93) 54 (24–82)
Gender, male, n (%) 100 (51.3 %) 83 (52.1 %) 17 (47.2 %)
Recurrent episode, n (%) 73 (37.4 %) 68 (42.8 %) 5 (13.9 %) 0.003
Trans-abdominal ultrasound, n (%) 195 (100 %)
Normal 175 (89.7 %) 151 (95.0 %) 24 (67 %)
Recurrent episode, n (%) 61 (40.4 %) 4 (17 %) 0.001
Sludge 14 (7.2 %) 4 (2.5 %) 10 (28 %)
Recurrent episode, n (%) 4 (100 %) 1 (10 %) 0.005
Polyp/s 6 (3.1 %) 4 (2.5 %) 2 (5.6 %)
Recurrent episode, n (%) 3 (75 %) 0 0.143
Table 1 Total patient cohort and
rate of recurrence of IAP Characteristic Total Expectant management
only (n = 129)
Cholecystectomy
(n = 66)
P value
Age, years, median, range 54 (15–93) 55 (15–93) 50 (17–82)
Gender, male, n (%) 100 (51.3 %) 72 (55.8 %) 28 (42.4 %) 0.096
Recurrent episode, n (%) 68 (42.8 %) 13 (19.7 %) 0.001
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pancreatitis without the ambiguity and complexity of exten-
sive radiological imaging, genetic testing, investigation of bile
composition or invasive endoscopic evaluation. These pa-
tients were managed in a real-time hospital environment with
standard acute inpatient care; the resources of which included
only clinical history and examination, blood tests, trans-
abdominal ultrasound and MRCP were obtained if the ultra-
sound showed no stones. The regional location of the hospital
where the study was conducted allowed for excellent long-
term surveillance of patients due to the isolated geography
and health resources. This study serves as a practical aid to
decision-making for the surgeon or gastroenterologist manag-
ing acute pancreatitis of uncertain aetiology with readily and
realistically available resources.
The most important outcome of our study was to determine
that cholecystectomy after the initial episode of acute pancre-
atitis confirmed with standard investigations includingMRCP
decreased the risk of a recurrent episode from 43 to 14% (P =
0.003). In addition, recurrent episodes seem to occur with
similar frequency regardless of cholecystectomy if it was to
be reserved until after a second episode.
The results of this study are supported by a recent
randomised controlled trial by Raty et al. 9 that compared
watchful waiting with laparoscopic cholecystectomy conduct-
ed as an elective procedure. Eighty-five patients were recruit-
ed during an outpatient visit after recovery from their episode
of pancreatitis and were carefully screened. The outpatient
work-up included a thorough focused history, blood tests for
alcohol abuse, repeat ultrasonography, genetic testing and
MRCP where liver function tests were deranged. Recurrence
rates were higher in the control group than the cholecystecto-
my group (14/46 versus 4/39; P = 0.016).9
Biliary sludge is almost always an ultrasound diagno-
sis and was not described until the advent of ultrasound
in the 1970s.10 Neither the optimal diagnostic method
nor the ramification of its diagnosis has been deter-
mined with certainty. Biliary sludge is a common find-
ing in patients with acute pancreatitis due to decreased
gallbladder distention and stasis. Other situations such
as pregnancy, prolonged fasting, total parenteral nutri-
tion, rapid weight loss and post abdominal surgery can
also result in reduced gallbladder motility and lead to
the development of sludge.11 The natural progression for
biliary sludge is to disappear, persist or lead to stone
formation. The sensitivity of trans-abdominal ultrasound
is only 55–60 % for biliary sludge, and for that reason
repeat ultrasound, endoscopic ultrasound or bile micros-
copy has been recommended in cases of IAP.10 Given
our retrospective study’s significant result in of reduc-
tion in recurrence rates following cholecystectomy
where sludge is detected on ultrasound, if a patient is
suitable for surgery, we believe cholecystectomy is
recommended.
When relying on ultrasound (which is what we do in the
real world), it is inevitable that patients with and without bil-
iary sludge are going to be included in this group of patients
with acute pancreatitis without identifiable cause. Acute pan-
creatitis without microlithiasis may represent a different group
of patients, one which cannot easily be differentiated in clin-
ical practice. As such, the benefits of cholecystectomy in such
patients may be due to those patients with sludge or
microcalculi. However, we believe the current state of affairs
with regards to the imaging supporting decision making fa-
vours cholecystectomy during the acute admission for pancre-
atitis without any other cause.
When deciding whether to offer cholecystectomy during
the primary episode of IAP, important considerations in
predicting occult biliary disease include the findings of
trans-abdominal ultrasound and the predictive value of liv-
er enzymes, in particular alanine aminotransferase (ALT).8
This study along with the other available evidence regard-
ing the biliary aetiology of idiopathic acute pancreatitis
suggest that one should not wait for patients to have a
second episode before performing cholecystectomy. Fit pa-
tients without an identifiable non-biliary cause for their
IAP should be considered for cholecystectomy. MRCP
Table 3 Patient characteristics
for patients managed expectantly
versus with cholecystectomy after
a second episode of idiopathic
acute pancreatitis
Characteristic Total Expectant management
(n = 45)
Cholecystectomy
(n = 23)
P value
Age, years, median, range 54 (15–93) 54 (15–93) 47 (17–81)
Gender, male, n (%) 33 (48.5 %) 24 (53 %) 9 (39 %)
Recurrent episode, n (%) 19 (27.9 %) 13 (29 %) 6 (26 %) 0.910
Trans-abdominal ultrasound, n (%) 68 (100 %)
Normal 61 (89.7 %) 42 (93.3 %) 18 (78 %)
Recurrent episode, n (%) 11 (26 %) 5 (28 %) 1.000
Sludge 4 (5.9 %) 2 (4 %) 2 (9 %)
Recurrent episode, n (%) 1 (50 %) 1 (50 %) 1.000
Polyp/s 3 (4.4 %) 1 (2 %) 2 (13 %)
Recurrent episode, n (%) 1 (100 %) 0 –
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and repeat ultrasonography have some worth in reassuring
both patient and surgeon that the operative course is the
correct one, but may delay intervention to until after a
further episode of pancreatitis or cloud the possibility of
a biliary cause by giving negative result. Certainly, in the
unfit or elderly patient, careful consideration should be
made to further non-invasive investigation, endoscopic ul-
trasound, microscopic bile crystal analysis, ERCP with or
without sphincterotomy or treatment with a cholelitholytic
bile acid.
The limitation of this study is that it has been conducted
retrospectively and in a single centre. There was of course an
underlying bias in those selected for cholecystectomy that is
not readily evident within the limitations of a retrospective
audit. The results shown here make clear the need for a pro-
spective study or a possible multicenter randomised control
trial looking into the use of only standard inpatient care.
Conclusion
The results of this study suggest that cholecystectomy is ben-
eficial in preventing recurrent IAP if performed after the pri-
mary episode. Further research could seek to determine an
accurate selection algorithm to predict which patients would
benefit most from cholecystectomy at their primary episode of
acute pancreatitis without identifiable cause. However, in pa-
tients fit for surgery, prophylactic cholecystectomy should be
the default treatment.
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